Some Children Lose Symptoms, Diagnosis of Autism

Some children who are accurately diagnosed in early childhood with autism lose the symptoms and the diagnosis as they grow older, a study supported by the National Institutes of Health has confirmed [1]. The research team made the finding by carefully documenting a prior diagnosis of autism in a small group of school-age children and young adults with no current symptoms of the disorder.

Autism?

NIH Study Finds Leisure-time Physical Activity Extends Life Expectancy As Much As 4.5 Years

Leisure-time physical activity is associated with longer life expectancy, even at relatively low levels of activity and regardless of body weight, according to a study by a team of researchers led by the National Cancer Institute (NCI), part of the National Institutes of Health. The study, which found that people who engaged in leisure-time physical activity had life expectancy gains of as much as 4.5 years, appeared Nov. 6, 2012, in PLoS Medicine [1].

Couple riding bikes

Bacterial Protein in House Dust Spurs Asthma

A bacterial protein in common house dust may worsen allergic responses to indoor allergens, according to research conducted by the National Institutes of Health and Duke University. The finding is the first to document the presence of the protein flagellin in house dust, bolstering the link between allergic asthma and the environment.

Bacteria with flagellum

Dark Matter DNA Active in Brain During Day-Night Cycle

Long stretches of DNA once considered inert “dark matter” of the genome — the over 98% of DNA that doesn’t code for proteins — appear to be uniquely active in a part of the brain known to control the body’s 24-hour cycle, according to researchers at the National Institutes of Health. The findings appear in the August 14th edition of the journal Proceedings of the National Academy of Sciences [1].

Dark Matter DNA

NIH Researchers Implicate Unique Cell Type in Multiple Sclerosis

Researchers at the National Institutes of Health have found evidence that a unique type of immune cell contributes to multiple sclerosis (MS). Their discovery helps define the effects of one of the newest drugs under investigation for treating MS — daclizumab — and could lead to a new class of drugs for treating MS and other autoimmune disorders.

Neuron